Exploring the UDP pocket of LpxC through amino acid analogs

被引:23
作者
Hale, Michael R. [1 ]
Hill, Pamela [1 ]
Lahiri, Sushmita [1 ]
Miller, Matthew D. [1 ]
Ross, Philip [1 ]
Alm, Richard [1 ]
Gao, Ning [1 ]
Kutschke, Amy [1 ]
Johnstone, Michele [1 ]
Prince, Bryan [1 ]
Thresher, Jason [1 ]
Yang, Wei [1 ]
机构
[1] AstraZeneca R&D Boston, Infect Innovat Med Unit, Waltham, MA 02451 USA
关键词
LpxC; Inhibitor; Antibiotic; Hydroxamate; GRAM-NEGATIVE BACTERIA; N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; ENDOTOXIN BIOSYNTHESIS; DEPENDENT DEACETYLASE; ANTIBACTERIAL AGENTS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OUTER-MEMBRANE; INHIBITOR; BINDING;
D O I
10.1016/j.bmcl.2013.02.055
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lipopolysaccharide (LPS) biosynthesis is an attractive antibacterial target as it is both conserved and essential for the survival of key pathogenic bacteria. Lipid A is the hydrophobic anchor for LPS and a key structural component of the outer membrane of Gram-negative bacteria. Lipid A biosynthesis is performed in part by a unique zinc dependent metalloamidase, LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase), which catalyzes the first non-reversible step in lipid A biosynthesis. The UDP portion of the LpxC substrate-binding pocket has been relatively unexplored. We have designed and evaluated a series of hydroxamate based inhibitors which explore the SAR of substitutions directed into the UDP pocket with a range of substituted alpha-amino acid based linkers. We also provide the first wild type structure of Pseudomonas aeruginosa LpxC which was utilized in the design of many of these analogs. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2362 / 2367
页数:6
相关论文
共 25 条
[1]  
ANDERSON MS, 1993, J BIOL CHEM, V268, P19858
[2]   Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding [J].
Barb, Adam W. ;
Jiang, Ling ;
Raetz, Christian R. H. ;
Zhou, Pei .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (47) :18433-18438
[3]   SEQUENCE-ANALYSIS, TRANSCRIPTIONAL ORGANIZATION, AND INSERTIONAL MUTAGENESIS OF THE ENVA GENE OF ESCHERICHIA-COLI [J].
BEALL, B ;
LUTKENHAUS, J .
JOURNAL OF BACTERIOLOGY, 1987, 169 (12) :5408-5415
[4]   logD7.4 modeling using Bayesian regularized neural networks.: Assessment and correction of the errors of prediction [J].
Bruneau, Pierre ;
McElroy, Nathan R. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (03) :1379-1387
[5]   Structure of the LpxC deacetylase with a bound substrate-analog inhibitor [J].
Coggins, BE ;
Li, XC ;
McClerren, AL ;
Hindsgaul, O ;
Raetz, CRH ;
Zhou, P .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (08) :645-651
[6]   Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine:: Insights into the mechanism and inhibitor design [J].
Coggins, BE ;
McClerren, AL ;
Jiang, L ;
Li, XC ;
Rudolph, J ;
Hindsgaul, O ;
Raetz, CRH ;
Zhou, P .
BIOCHEMISTRY, 2005, 44 (04) :1114-1126
[7]   Lipid trafficking to the outer membrane of Gram-negative bacteria [J].
Doerrler, WT .
MOLECULAR MICROBIOLOGY, 2006, 60 (03) :542-552
[8]   Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase [J].
Gennadios, Heather A. ;
Whittington, Douglas A. ;
Li, Xuechen ;
Fierke, Carol A. ;
Christianson, David W. .
BIOCHEMISTRY, 2006, 45 (26) :7940-7948
[9]   Binding of uridine 5′-diphosphate in the "Basic patch" of the zinc deacetylase LpxC and implications for substrate binding [J].
Gennadios, Heather A. ;
Christianson, David W. .
BIOCHEMISTRY, 2006, 45 (51) :15216-15223
[10]  
Harvood E., 2004, Antibacterial Agents, Patent No. [2004/062601, 2004062601]